Clovis Oncology, Inc. Proceeds from Convertible Debt
Clovis Oncology, Inc. reported Proceeds from Convertible Debt of $254.88 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2020-02-26
- Clovis Oncology, Inc. proceeds from convertible debt for the quarter ending 2019-12-31 was -$86.00K.
- Clovis Oncology, Inc. proceeds from convertible debt for the quarter ending 2018-12-31 was $0.00.
- Clovis Oncology, Inc. proceeds from convertible debt for the quarter ending 2018-09-30 was -$148.00K.
- Clovis Oncology, Inc. proceeds from convertible debt for the quarter ending 2017-12-31 was $0.00.
- Clovis Oncology, Inc. proceeds from convertible debt for fiscal 2019 was $254.88M, a 12.38% decline from fiscal 2018.
- Clovis Oncology, Inc. proceeds from convertible debt for fiscal 2018 was $290.89M.
- Clovis Oncology, Inc. proceeds from convertible debt for fiscal 2017 was $0.00.
- Clovis Oncology, Inc. proceeds from convertible debt for fiscal 2016 was $0.00.
| Period end | Proceeds from Convertible Debt 1 month | Proceeds from Convertible Debt 1 month as first filed | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 9 month as first filed | Proceeds from Convertible Debt 12 month | Proceeds from Convertible Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | -$86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $254.88M 10-K · filed 2020-02-26 | ||||||
| 2019-09-30 | $254.97M 10-Q · filed 2019-11-07 | |||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$148.00K derived: sum of 2 quarters · filed 2020-02-26 | $290.89M 10-K · filed 2020-02-26 | |||||
| 2018-09-30 | -$148.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $290.89M 10-Q · filed 2019-11-07 | ||||||
| 2018-06-30 | $291.04M 10-Q · filed 2019-08-02 | |||||||
| 2018-04-30 | $290.90M 10-K · filed 2019-02-28 | $291.00M 10-Q · filed 2018-08-02 | ||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $0.00 10-K · filed 2019-02-28 | |||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 10-Q · filed 2018-11-01 | ||||||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-02 | |||||||
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 | |||||||
| 2015-12-31 | $0.00 10-K · filed 2017-02-23 | |||||||
| 2014-12-31 | -$22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $278.31M 10-K · filed 2017-02-23 | $287.50M 10-K · filed 2015-02-27 | |||||
| 2014-09-30 | $278.33M 10-Q · filed 2015-11-06 | $287.50M 10-Q · filed 2014-11-07 |